非侵襲性肝臓モニター市場：検査タイプ、技術、用途、エンドユーザー、患者タイプ、対象疾患別-2025-2030年の世界予測

非侵襲性肝臓モニター市場は、2024年に80億4,000万米ドルと評価され、2025年にはCAGR 6.98%で85億7,000万米ドルに成長し、2030年には120億5,000万米ドルに達すると予測されています。

非侵襲性肝モニタ市場は、より安全で患者にやさしい診断ソリューションに対する需要の高まりを受けて、大きな進化を遂げています。近年、患者の不快感を軽減し、回復時間を最短にし、合併症のリスクを下げるという臨床ニーズの高まりを受けて、従来の侵襲的な方法からの移行が顕著になっています。テクノロジーの進歩、規制ガイドラインの強化、医療従事者の意識の高まりが、非侵襲的手法の採用に拍車をかけています。現在では、革新的な画像診断とバイオマーカーに基づくツールが合流し、肝疾患の診断と管理を再構築しています。本市場概要では、これらの非侵襲的手法の成長の背景にある新たな動向と戦略的促進要因について詳しく解説します。このエグゼクティブサマリーは、信頼性、正確性、リアルタイムモニタリング機能に重点を置き、これらの技術が臨床現場と患者の転帰の両方にもたらす変革的な影響を理解するための土台を築くものです。市場の現在と将来の方向性を舵取りする動向を支えるデータ主導の洞察と包括的な調査へのご招待です。

非侵襲性肝モニタ市場を形成する市場情勢の変化

非侵襲性肝臓モニター分野は、医療診断における従来のパラダイムを再定義する変革的なシフトを経験しています。革新的な臨床アプリケーションと強力な技術の進歩の融合は、ヘルスケアプロバイダーが肝臓の状態を評価する方法を再形成しています。画像診断やバイオマーカー検出における画期的な進歩は、診断精度を向上させるだけでなく、肝機能に関するダイナミックで定量的な洞察をもたらしています。企業も研究開発も研究開発に多額の投資を行っており、その結果、計算アルゴリズムが強化され、より精密な測定技術が開発されています。さらに、患者の期待の変化と予防ヘルスケアへの関心の高まりが、非侵襲性モニターを日常的なスクリーニング・プロセスに組み込むきっかけとなっています。支払者とヘルスケアシステムは、早期発見の長期的な経済的メリットを認識し始めており、これが市場の勢いをさらに加速させています。規制機関は、新たな技術に対応するために承認経路を合理化し、それによってより広範なアクセシビリティと信頼を確保しています。この進化するエコシステムは、臨床医、技術者、規制専門家の協力的な取り組みによって特徴付けられ、継続的なモニタリングと低侵襲的な評価がより良い臨床転帰と全体的な患者の幸福を促進する新時代の到来を告げるものです。

包括的な市場セグメンテーションによる主要な洞察

詳細な市場セグメンテーションにより、非侵襲性肝臓モニター業界を詳細に理解し、成長とイノベーションのための多様な道筋を明らかにします。分析ではまず、検査を血液ベースのバイオマーカー検査と画像ベースの検査に分類し、診断アプローチを差別化するための段階を設定しています。これらの方法論の骨格を形成する技術は、コンピュータ断層撮影（CT）ベースの技術、磁気共鳴エラストグラフィ（MRE）、近赤外分光法（NIRS）、血清バイオマーカーパネル＆スコアリング、超音波エラストグラフィに及んでいます。さらに、アプリケーションに基づくセグメンテーションにより、疾患の病期分類とモニタリング、疾患の早期診断、手術後のモニタリングといった重要な役割が浮き彫りにされ、それぞれが患者のケアを最適化するための重要なノードとして機能しています。エンドユーザーレベルでは、診断センター、病院、診療所、研究機関における動態を調査し、実際のアプリケーションを通じてイノベーションを推進しています。成人、老年、小児といった患者別の区分では、特定の人口統計学的なニーズに焦点を当てやすいよう、カスタマイズされたインサイトが提供されます。さらに、肝硬変、脂肪性肝疾患、肝炎、肝線維症などの対象疾患別に市場をセグメント化し、肝炎についてはさらにB型肝炎とC型肝炎に細分化することで、市場の各側面を的確に捉えた戦略的アプローチを可能にしています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化が世界的に進み、高度なヘルスケアモニタリングツールが必要に
    • 不快感や関連するリスクが軽減されたため、診断手順に対する患者の受け入れが増加している
    • 肝疾患の診断と治療の改善を目的とした政府の取り組みと資金援助
  • 抑制要因
    • 高度な非侵襲性肝臓モニタリングシステムの購入と導入のための多額の資本投資
  • 機会
    • デジタルヘルスの動向により遠隔医療と遠隔患者モニタリングが拡大
    • テクノロジーの統合を促進するテクノロジー企業とヘルスケア提供者間の協力パートナーシップ
  • 課題
    • 非侵襲性肝臓モニタリング装置の品質管理を保証する高い生産およびサプライチェーンの問題
• 市場セグメンテーション分析
  • 検査の種類：血液ベースのバイオマーカー検査は、処理時間が短く、費用対効果が高いため、
  • 対象疾患：肥満やアルコール摂取による脂肪肝疾患の増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 非侵襲性肝臓モニター市場テストの種類別

• 血液ベースのバイオマーカー検査
• 画像検査

第7章 非侵襲性肝臓モニター市場：技術別

• コンピュータ断層撮影（CT）ベースの技術
• 磁気共鳴エラストグラフィー（MRE）
• 近赤外線分光法（NIRS）
• 血清バイオマーカーパネルとスコアリング
• 超音波エラストグラフィー

第8章 非侵襲性肝臓モニター市場：用途別

• 病気のステージングとモニタリング
• 病気の早期診断
• 術後モニタリング

第9章 非侵襲性肝臓モニター市場：エンドユーザー別

• 診断センター
• 病院・クリニック
• 調査機関

第10章 非侵襲性肝臓モニター市場患者タイプ別

• 成人用
• 高齢者
• 小児科

第11章 非侵襲性肝臓モニター市場標的疾患別

• 肝硬変
• 脂肪肝疾患
• 肝炎
  • B型肝炎
  • C型肝炎
• 肝線維症

第12章 南北アメリカの非侵襲性肝臓モニター市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の非侵襲性肝臓モニター市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの非侵襲性肝臓モニター市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Alpinion Medical Systems USA Inc.
• Bruker Corporation GmbH
• Canon Medical Systems Corporation
• Chison Medical Imaging Co., Ltd.
• Clarius Mobile Health, Inc.
• Echosens S.A.
• Esaote S.p.A.
• F. Hoffmann-La Roche AG
• Fujifilm Holdings Corporation
• GE HealthCare Technologies Inc.
• Hologic, Inc.
• iLiv Diagnostics Inc.
• Konica Minolta, Inc.
• Koninklijke Philips N.V.
• Mindray Medical International Limited
• Perspectum Diagnostics Ltd.
• Quibim
• Randox Laboratories Ltd.
• Resonance Health Limited
• Resoundant, Inc.
• Samsung Medison Co., Ltd.
• Siemens Healthcare Private Limited
• Supersonic Imagine S.A.
• Wuxi HISKY Medical Technologies Co., Ltd.

LIST OF FIGURES

• FIGURE 1. NON-INVASIVE LIVER MONITOR MARKET MULTI-CURRENCY
• FIGURE 2. NON-INVASIVE LIVER MONITOR MARKET MULTI-LANGUAGE
• FIGURE 3. NON-INVASIVE LIVER MONITOR MARKET RESEARCH PROCESS
• FIGURE 4. NON-INVASIVE LIVER MONITOR MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. NON-INVASIVE LIVER MONITOR MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. NON-INVASIVE LIVER MONITOR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. NON-INVASIVE LIVER MONITOR MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NON-INVASIVE LIVER MONITOR MARKET DYNAMICS
• TABLE 7. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY BLOOD-BASED BIOMARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY IMAGING-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT)-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY (MRE), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY NEAR-INFRARED SPECTROSCOPY (NIRS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY SERUM BIOMARKER PANELS & SCORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY DISEASE STAGING & MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY EARLY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY POST-SURGERY MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY FATTY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY LIVER FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 58. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 59. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 64. CANADA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 95. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 96. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 101. CHINA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 102. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 103. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 108. INDIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 222. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 223. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 227. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 228. ITALY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 250. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 251. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 252. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 254. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 256. POLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 257. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 258. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 259. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 262. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 263. QATAR NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES NON-INVASIVE LIVER MONITOR MARKET SIZE, BY HEPATITIS, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TEST TYPES, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM NON-INVASIVE LIVER MONITOR MARKET SIZE, BY TARGETED DISEASES

The Non-Invasive Liver Monitor Market was valued at USD 8.04 billion in 2024 and is projected to grow to USD 8.57 billion in 2025, with a CAGR of 6.98%, reaching USD 12.05 billion by 2030.

The non-invasive liver monitor market has witnessed significant evolution in response to rising demand for safer and more patient-friendly diagnostic solutions. In recent years, there has been a pronounced shift away from traditional invasive methods, driven by the increasing clinical need to reduce patient discomfort, minimize recovery time, and lower the risk of complications. Advancements in technology, tighter regulatory guidelines, and heightened awareness among healthcare providers have collectively spurred the adoption of non-invasive techniques. The landscape today presents a confluence of innovative imaging and biomarker-based tools that are reshaping liver disease diagnosis and management. This market overview provides an in-depth look at the emerging trends and the strategic drivers behind the growth of these non-invasive modalities. With an emphasis on reliability, accuracy, and real-time monitoring capabilities, this executive summary lays the foundation for understanding the transformative impact these technologies are having on both clinical practice and patient outcomes. It is an invitation to explore the data-driven insights and comprehensive research that underpin the trends steering the market's current and future direction.

Transformative Market Shifts Shaping the Non-Invasive Liver Monitor Landscape

The non-invasive liver monitor sector is experiencing transformative shifts that are redefining traditional paradigms in medical diagnostics. The convergence of robust technological advancements with innovative clinical applications has reshaped how healthcare providers evaluate liver conditions. Breakthroughs in imaging modalities and biomarker detection have not only enhanced diagnostic accuracy but also provided dynamic and quantifiable insights into liver function. Companies and research institutions alike are investing heavily in research and development, resulting in enhanced computational algorithms and more precise measurement techniques. Additionally, changing patient expectations and an increased focus on preventive healthcare have catalyzed the integration of non-invasive monitors in routine screening processes. Payers and healthcare systems are beginning to recognize the long-term economic benefits of early detection, which further fuels market momentum. Regulatory bodies are streamlining approval pathways to accommodate emerging technologies, thereby ensuring broader accessibility and trust. This evolving ecosystem is marked by collaborative efforts among clinicians, engineers, and regulatory experts, heralding a new era where continuous monitoring and minimally invasive assessments drive better clinical outcomes and overall patient well-being.

Key Insights from Comprehensive Market Segmentation

Detailed market segmentation provides an intricate understanding of the non-invasive liver monitor industry, revealing diverse pathways for growth and innovation. The analysis begins by categorizing the tests into blood-based biomarker tests and imaging-based tests, which sets the stage for differentiating diagnostic approaches. Technologies forming the backbone of these methodologies span across Computed Tomography (CT)-Based Techniques, Magnetic Resonance Elastography (MRE), Near-Infrared Spectroscopy (NIRS), Serum Biomarker Panels & Scoring, and Ultrasound Elastography. Further segmentation based on application highlights the critical roles of disease staging and monitoring, early disease diagnosis, and post-surgery monitoring, each serving as a vital node in optimizing patient care. The segmentation extends to the end-user level, examining the dynamics within diagnostic centers, hospitals and clinics, as well as research institutions that drive innovation through real-world application. Patient-specific divisions-ranging from adult, geriatric, to pediatric groups-offer tailored insights that facilitate focus on specific demographic needs. Moreover, the market is segmented by targeted diseases such as cirrhosis, fatty liver disease, hepatitis, and liver fibrosis, with a nuanced exploration of hepatitis further broken down into hepatitis B and hepatitis C. This layered segmentation enables a strategic approach, ensuring that each facet of the market is addressed with precision.

Based on Test Types, market is studied across Blood-Based Biomarker Tests and Imaging-Based Tests.

Based on Technology, market is studied across Computed Tomography (CT)-Based Techniques, Magnetic Resonance Elastography (MRE), Near-Infrared Spectroscopy (NIRS), Serum Biomarker Panels & Scoring, and Ultrasound Elastography.

Based on Application, market is studied across Disease Staging & Monitoring, Early Disease Diagnosis, and Post-Surgery Monitoring.

Based on End-User, market is studied across Diagnostic Centers, Hospitals & Clinics, and Research Institutions.

Based on Patient Type, market is studied across Adult, Geriatric, and Pediatric.

Based on Targeted Diseases, market is studied across Cirrhosis, Fatty Liver Disease, Hepatitis, and Liver Fibrosis. The Hepatitis is further studied across Hepatitis B and Hepatitis C.

Key Regional Insights & Emerging Global Trends

Regional analysis indicates that market maturity and adoption rates vary significantly across global territories. In the Americas, robust healthcare infrastructure coupled with increasing investments in research have catalyzed a rapid assimilation of non-invasive diagnostic techniques. The Europe, Middle East & Africa region, with its diverse regulatory frameworks and varying levels of technological integration, presents a mix of mature and emerging markets where tailored regional strategies are essential. Meanwhile, the Asia-Pacific region stands out due to its expansive patient base, rapid urbanization, and government initiatives aimed at modernizing healthcare services. Each of these regions contributes distinctively to the global market landscape. The Americas continue to lead in terms of technological innovation and funding, Europe and parts of Africa are leveraging collaborative networks and regulatory advancements to boost market penetration, and Asia-Pacific is witnessing significant growth driven by an emphasis on preventive healthcare and scalable clinical applications. Together, these regions paint a dynamic picture of a rapidly evolving global market that is responsive to local needs while remaining interconnected through shared technological trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Major Industry Players and Strategic Business Insights

The competitive landscape of the non-invasive liver monitor market is largely defined by a cohort of pioneering companies committed to innovation and excellence. Industry leaders such as Abbott Laboratories, Alpinion Medical Systems USA Inc., and Bruker Corporation GmbH are at the forefront of leveraging advanced technologies to refine diagnostic accuracy. Canon Medical Systems Corporation and Chison Medical Imaging Co., Ltd. have made significant strides in developing cutting-edge imaging systems, while Clarius Mobile Health, Inc. and Echosens S.A. continue to drive transformation through mobile and portable diagnostic devices. Other influential players, including Esaote S.p.A., F. Hoffmann-La Roche AG, and Fujifilm Holdings Corporation, have expanded their portfolio to include integrated solutions that combine biomarker panels with imaging data. GE HealthCare Technologies Inc., Hologic, Inc., and iLiv Diagnostics Inc. are enhancing market reach through robust clinical partnerships and research collaborations. Notably, companies such as Konica Minolta, Inc., Koninklijke Philips N.V., and Mindray Medical International Limited are spearheading efforts to integrate automation and digital analytics into routine diagnostics. Perspectum Diagnostics Ltd., Quibim, Randox Laboratories Ltd., Resonance Health Limited, Resoundant, Inc., Samsung Medison Co., Ltd., Siemens Healthcare Private Limited, Supersonic Imagine S.A., and Wuxi HISKY Medical Technologies Co., Ltd. also play critical roles, collectively enriching the ecosystem with a diverse range of innovative products and strategic insights.

The report delves into recent significant developments in the Non-Invasive Liver Monitor Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alpinion Medical Systems USA Inc., Bruker Corporation GmbH, Canon Medical Systems Corporation, Chison Medical Imaging Co., Ltd., Clarius Mobile Health, Inc., Echosens S.A., Esaote S.p.A., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Hologic, Inc., iLiv Diagnostics Inc., Konica Minolta, Inc., Koninklijke Philips N.V., Mindray Medical International Limited, Perspectum Diagnostics Ltd., Quibim, Randox Laboratories Ltd., Resonance Health Limited, Resoundant, Inc., Samsung Medison Co., Ltd., Siemens Healthcare Private Limited, Supersonic Imagine S.A., and Wuxi HISKY Medical Technologies Co., Ltd.. Actionable Recommendations for Future Industry Leadership

Industry leaders must adopt a multi-faceted strategy to harness the full potential of the non-invasive liver monitor market. First, investing in next-generation technological platforms that integrate both imaging and biomarker data can provide more comprehensive diagnostic insights, thus improving both precision and patient outcomes. Leaders should also prioritize collaborations with academic institutions and regulatory agencies to expedite the validation and clinical acceptance of emerging technologies. Expanding geographical footprints by targeting underpenetrated regions, while simultaneously adapting solutions to meet localized healthcare needs, stands as a robust strategy. Furthermore, capitalizing on digital transformations, such as incorporating artificial intelligence and machine learning algorithms into diagnostic workflows, will be essential in translating complex data into actionable insights. Emphasis should also be placed on developing customized solutions that cater to distinct patient segments, including adult, geriatric, and pediatric groups, ensuring a tailored approach. Strategic investments in research and maintaining an agile response to market needs will enable companies to not only sustain but also enhance their competitive advantage in this rapidly evolving sector.

Conclusion and Future Outlook

In conclusion, the non-invasive liver monitor market is on the cusp of a transformative era marked by rapid technological advancements and evolving clinical applications. This executive summary has elucidated how innovative diagnostic methods are reshaping clinical best practices by offering safer, more effective, and patient-centric alternatives to conventional procedures. The comprehensive segmentation insights, coupled with regional market dynamics and competitive landscape analyses, provide a clear roadmap for how different facets of the market interconnect. Moving forward, the integration of emerging technologies such as advanced imaging modalities and smart analytics will not only drive market growth but also enhance patient care significantly. The synthesis of strategic recommendations underscores the importance of cross-disciplinary collaborations and continuous innovation. As the market continues to mature, stakeholders are encouraged to adapt agile strategies that address both current challenges and future opportunities, ensuring that the progress achieved today paves the way for sustained success tomorrow.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing aging population globally necessitating advanced healthcare monitoring tools
    • 5.1.1.2. Growing patient acceptance of diagnostic procedures due to reduced discomfort and associated risks
    • 5.1.1.3. Government initiatives and funding support aimed at improving liver disease diagnosis and treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High capital investment for purchasing and implementing advanced non-invasive liver monitoring systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of telemedicine and remote patient monitoring enabled by digital health trends
    • 5.1.3.2. Collaborative partnerships between tech companies and healthcare providers promoting technology integration
  • 5.1.4. Challenges
    • 5.1.4.1. High production and supply chain issues ensuring quality control for non-invasive liver monitoring devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Test Types: Utilization of blood-based biomarker tests for their rapid turnaround time, cost-effectiveness
  • 5.2.2. Targeted Diseases: Growing of fatty liver disease due to obesity and alcohol consumption
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Non-Invasive Liver Monitor Market, by Test Types

• 6.1. Introduction
• 6.2. Blood-Based Biomarker Tests
• 6.3. Imaging-Based Tests

7. Non-Invasive Liver Monitor Market, by Technology

• 7.1. Introduction
• 7.2. Computed Tomography (CT)-Based Techniques
• 7.3. Magnetic Resonance Elastography (MRE)
• 7.4. Near-Infrared Spectroscopy (NIRS)
• 7.5. Serum Biomarker Panels & Scoring
• 7.6. Ultrasound Elastography

8. Non-Invasive Liver Monitor Market, by Application

• 8.1. Introduction
• 8.2. Disease Staging & Monitoring
• 8.3. Early Disease Diagnosis
• 8.4. Post-Surgery Monitoring

9. Non-Invasive Liver Monitor Market, by End-User

• 9.1. Introduction
• 9.2. Diagnostic Centers
• 9.3. Hospitals & Clinics
• 9.4. Research Institutions

10. Non-Invasive Liver Monitor Market, by Patient Type

• 10.1. Introduction
• 10.2. Adult
• 10.3. Geriatric
• 10.4. Pediatric

11. Non-Invasive Liver Monitor Market, by Targeted Diseases

• 11.1. Introduction
• 11.2. Cirrhosis
• 11.3. Fatty Liver Disease
• 11.4. Hepatitis
  • 11.4.1. Hepatitis B
  • 11.4.2. Hepatitis C
• 11.5. Liver Fibrosis

12. Americas Non-Invasive Liver Monitor Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Non-Invasive Liver Monitor Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Non-Invasive Liver Monitor Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Samaritan Family Health Center launch new non-invasive FibroScan service enhances liver health diagnostics
  • 15.3.2. Legacy MD launch non-invasive liver testing with Fibroscan
  • 15.3.3. Quibim launch AI-powered non-invasive liver monitor
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alpinion Medical Systems USA Inc.
• 3. Bruker Corporation GmbH
• 4. Canon Medical Systems Corporation
• 5. Chison Medical Imaging Co., Ltd.
• 6. Clarius Mobile Health, Inc.
• 7. Echosens S.A.
• 8. Esaote S.p.A.
• 9. F. Hoffmann-La Roche AG
• 10. Fujifilm Holdings Corporation
• 11. GE HealthCare Technologies Inc.
• 12. Hologic, Inc.
• 13. iLiv Diagnostics Inc.
• 14. Konica Minolta, Inc.
• 15. Koninklijke Philips N.V.
• 16. Mindray Medical International Limited
• 17. Perspectum Diagnostics Ltd.
• 18. Quibim
• 19. Randox Laboratories Ltd.
• 20. Resonance Health Limited
• 21. Resoundant, Inc.
• 22. Samsung Medison Co., Ltd.
• 23. Siemens Healthcare Private Limited
• 24. Supersonic Imagine S.A.
• 25. Wuxi HISKY Medical Technologies Co., Ltd.